133 related articles for article (PubMed ID: 12029550)
21. Radioiodine Scan Index: A Simplified, Quantitative Treatment Response Parameter for Metastatic Thyroid Carcinoma.
Oh JR; Ahn BC; Jeong SY; Lee SW; Lee J
Nucl Med Mol Imaging; 2015 Sep; 49(3):174-81. PubMed ID: 26279690
[TBL] [Abstract][Full Text] [Related]
22. Male Sex Is Not a Risk Factor for Prognosis in Postoperative Thyroid Cancer Patients: A Propensity Score Matching Study.
Zhou Y; Wang Y; Zhang Z; Yin X; Liu J; Zheng W
J Clin Endocrinol Metab; 2023 Nov; 108(12):3330-3337. PubMed ID: 37267432
[TBL] [Abstract][Full Text] [Related]
23. Long-term eradication of locally recurrent invasive follicular thyroid carcinoma after taxane-based concomitant chemoradiotherapy.
Tulloch-Reid M; Skarulis MC; Sherman SI; Sarlis NJ; Santarpia L
Anticancer Res; 2009 Nov; 29(11):4665-71. PubMed ID: 20032418
[TBL] [Abstract][Full Text] [Related]
24. Radioiodine whole body scan pitfalls in differentiated thyroid cancer.
Basso C; Colapinto A; Vicennati V; Gambineri A; Pelusi C; Di Dalmazi G; Rizzini EL; Tabacchi E; Golemi A; Calderoni L; Fanti S; Pagotto U; Repaci A
Endocrine; 2024 Mar; ():. PubMed ID: 38498129
[TBL] [Abstract][Full Text] [Related]
25. Dosimetry during iodine-131 therapy - a technical point of view from a single centre's own experience.
Chalewska W; Cegla P; Moczulska A; Strzemecka E; Sackiewicz A; Dedecjus M
Nucl Med Rev Cent East Eur; 2024; 27(0):1-5. PubMed ID: 38529769
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of Empirical 131I Radioiodine Therapy in Well-Differentiated Thyroid Carcinoma Patients With Thyroglobulin-Elevated Negative Iodine Scintigraphy Syndrome: A Systematic Review and Meta-analysis.
Kim K; Hong CM; Ha M; Choi M; Bang JI; Park S; Seo Y; Chong A; Oh SW; Lee SW
Clin Nucl Med; 2024 Jun; ():. PubMed ID: 38861375
[TBL] [Abstract][Full Text] [Related]
27. Dynamic Risk Stratification for Predicting Treatment Response in Differentiated Thyroid Cancer.
Giannoula E; Melidis C; Papadopoulos N; Bamidis P; Raftopoulos V; Iakovou I
J Clin Med; 2020 Aug; 9(9):. PubMed ID: 32825789
[TBL] [Abstract][Full Text] [Related]
28. Clinical use of thyroglobulin: not only thyroid cancer.
Berlińska A; Świątkowska-Stodulska R
Endocrine; 2024 Jan; ():. PubMed ID: 38182855
[TBL] [Abstract][Full Text] [Related]
29. Beard Contamination With 131I Diagnosed by SPECT/CT in a Patient With Differentiated Thyroid Cancer.
Makarewicz J; Rudzki J
Clin Nucl Med; 2024 May; ():. PubMed ID: 38768062
[TBL] [Abstract][Full Text] [Related]
30. Corrigendum: Incorporation size of lymph node metastasis focus and pre-ablation stimulated Tg could more effectively predict clinical outcomes in differentiated thyroid cancer patients without distant metastases.
Xie J; Chen P; Wang J; Luo X; Luo J; Xiong X; Li C; Pan L; Wu J; Feng H; Ouyang W
Front Endocrinol (Lausanne); 2023; 14():1221004. PubMed ID: 37522125
[TBL] [Abstract][Full Text] [Related]
31. Respective roles of thyroglobulin, radioiodine imaging, and positron emission tomography in the assessment of thyroid cancer.
Lind P; Kohlfürst S
Semin Nucl Med; 2006 Jul; 36(3):194-205. PubMed ID: 16762610
[TBL] [Abstract][Full Text] [Related]
32. Radioiodine in Differentiated Thyroid Carcinoma: Do We Need Diagnostic Pre-Ablation Iodine-123 Scintigraphy to Optimize Treatment?
de Koster EJ; Sulaiman T; Hamming JF; Schepers A; Snel M; van Velden FHP; de Geus-Oei LF; Vriens D
Diagnostics (Basel); 2021 Mar; 11(3):. PubMed ID: 33808843
[TBL] [Abstract][Full Text] [Related]
33. Bone metastases in thyroid cancer.
Iñiguez-Ariza NM; Bible KC; Clarke BL
J Bone Oncol; 2020 Apr; 21():100282. PubMed ID: 32154098
[TBL] [Abstract][Full Text] [Related]
34. Clinical features of bone metastasis for differentiated thyroid carcinoma: A study of 21 patients from a Tunisian center.
Kallel F; Hamza F; Charfeddine S; Amouri W; Jardak I; Ghorbel A; Guermazi F
Indian J Endocrinol Metab; 2014 Mar; 18(2):185-90. PubMed ID: 24741514
[TBL] [Abstract][Full Text] [Related]
35. Surgery and survival outcomes of 22 patients with epidural spinal cord compression caused by thyroid tumor spinal metastases.
Zhang D; Yin H; Wu Z; Yang X; Liu T; Xiao J
Eur Spine J; 2013 Mar; 22(3):569-76. PubMed ID: 23076644
[TBL] [Abstract][Full Text] [Related]
36. Somatostatin receptor SPECT.
Pepe G; Moncayo R; Bombardieri E; Chiti A
Eur J Nucl Med Mol Imaging; 2012 Feb; 39 Suppl 1():S41-51. PubMed ID: 22388628
[TBL] [Abstract][Full Text] [Related]
37. Comparison of radioiodine biokinetics following the administration of recombinant human thyroid stimulating hormone and after thyroid hormone withdrawal in thyroid carcinoma.
Luster M; Sherman SI; Skarulis MC; Reynolds JR; Lassmann M; Hänscheid H; Reiners C
Eur J Nucl Med Mol Imaging; 2003 Oct; 30(10):1371-7. PubMed ID: 12856155
[TBL] [Abstract][Full Text] [Related]
38. Sensitivity of 123I whole-body scan and thyroglobulin in the detection of metastases or recurrent differentiated thyroid cancer.
de Geus-Oei LF; Oei HY; Hennemann G; Krenning EP
Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):768-74. PubMed ID: 12029550
[TBL] [Abstract][Full Text] [Related]
39. Thyroglobulin and low-dose iodine-131 and technetium-99m-tetrofosmin whole-body scintigraphy in differentiated thyroid carcinoma.
Gallowitsch HJ; Mikosch P; Kresnik E; Unterweger O; Gomez I; Lind P
J Nucl Med; 1998 May; 39(5):870-5. PubMed ID: 9591591
[TBL] [Abstract][Full Text] [Related]
40. [Patients treated for differentiated thyroid cancer with negative 131I whole-body scans and elevated thyroglobulin levels: a possible course].
Gutiérrez Cardo AL; Rodríguez Rodríguez JR; Borrego Dorado I; Navarro González E; Tirado Hospital JL; Vázquez Albertino R
Rev Esp Med Nucl; 2007; 26(3):138-45. PubMed ID: 17524307
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
